Ambu A/S (OTCMKTS:AMBBY) Sets New 1-Year Low – Time to Sell?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) reached a new 52-week low during trading on Thursday . The stock traded as low as $9.70 and last traded at $9.98, with a volume of 600 shares. The stock had previously closed at $10.65.

Ambu A/S Stock Performance

The company has a current ratio of 2.86, a quick ratio of 1.67 and a debt-to-equity ratio of 0.08. The firm has a fifty day moving average price of $10.91 and a 200 day moving average price of $12.78. The firm has a market cap of $2.35 billion, a PE ratio of 32.19 and a beta of 1.06.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.07 EPS for the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.